Tachikawa Hospital

Tachikawa 190-8531

1 studies enrolling now · 2 studies all time

What they study most

Alzheimer's Disease, Amyloid, Cognitive Dysfunction, Lewy Body Disease, Synucleinopathies

Studies at this site

• A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7) — Recruiting now
• A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3) — Running, not enrolling